주식/증권
📈 긍정적
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge?
요약
Illumina shares surge 98.7% in a year as NovaSeq X adoption accelerates, clinical sequencing demand grows, and the company tops Q1 2026 guidance.